Speakers' Presentations 2012
New insights in the pathophysiology of ankylosing spondylitis
Dominique Baeten, Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, THE NETHERLANDS
Diagnosis and Management of Sacroilitis-HOW TO use the MRI in clinical practice
Dr. Xenophon Baraliakos, Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, GERMANY
Recent Developments in the Management of Gout
Michael A. Becker, Professor Emeritus of Medicine, Department of Rheumatology, University of Chicago Medical Center, Chicago, IL, USA
Guidance and guidelines for newly diagnosed lupus patients
Sue Brown, Clinical Nurse Specialist in Connective Tissue Diseases, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Bath, UK
Juvenile-onset SpA
Juvenile onset spondyloarthritis
Juvenile onset spondyloarthritis (2)
Rubén Burgos-Vargas, Professor, Hospital General De Mexico and Universidad Nacional Autonoma de Mexico, MEXICO
Management of the catastrophic antiphospholipid syndrome
Ricard Cervera, Dr., Head of Department Of Autoimmune Diseases, Hospital Clinic, Barcelona, SPAIN
Maximizing Treatment Approaches in Psoriasis
Vinod Chandran, Assistant Professor, University of Toronto, Department of Medicine, Division of Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada
Excellence in Rheumatology Quiz
Kaushik Chaudhuri, Clinical Director of Rheumatology, University Hospital, Coventry, UK
The Epidemiology of Cardiovascular Disease in SLE: Who is at risk and who much?
Karen H. Costenbader, Associate Physician and Co-Director, Lupus Center, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Associate Professor of Medicine, Harvard Medical School Boston, Massachusetts, USA
Ultrasound in the Spondyloarthritis
Eugenio de Miguel, Hospital Universitario La Paz, Universidad Autónoma de Madrid, SPAIN
Exchanging personal experiences and ideas about cardiovascular risk management (according to guidelines) and patients responsibilities (need for self-management & self-monitoring)
Maarten de Wit, Representative for research and international collaboration, Dutch League of Arthritis Patient organisations, Zaltbommel, The Netherlands
Lupus nephritis: issues in pathophysiology and clinical trials
Betty Diamond, M.D. Head, The Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, North Shore LIJ – Health Systems, New York, USA
Assessment of psoriatic arthritis and psoriasis in daily clinical practice
Jaap Fransen, Clinical Epidemiologist, Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, THE NETHERLANDS
What authors, reviewers and editors should know about impact factors
Armen Yuri Gasparyan, MD, PhD, FESC, Associate Professor of Medicine, ARMENIA
Osteoporosis therapies: past, present and future
Piet Geusens, Professor, MD, PhD, Internal Medicine/Rheumatology, Maastricht University Medical Center & University Hasselt, Maastricht, The Netherlands & Biomedical Research Center, University Hasselt, Belgium
Immunomodulation and Biologics in Anca-Associated Vasculitides
LoΪc Guillevin, Professor of Medicine and Therapeutics & Head of the Department of Internal Medicine, Cochin Hospital, University of Paris Descartes, Paris, FRANCE
Mindfulness Meditation
What can a psychologist add to patient management?
Elizabeth Hale, Chartered Health Psychologist / Research Psychologist, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK
New insights into the pathophysiology of JIA
Raphael Hirsch, Aldo V. Londino Professor of Pediatrics, Vice Chair for Faculty Development, Chief, Division of Rheumatology, Children’s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, USA
Osteoarthritis: Update 2012
Marc C. Hochberg, Professor of Medicine and Epidemiology and Public Health and Head, Division of Rheumatology and Clinical Immunology, School of Medicine, University of Maryland, USA
Giant Cell Arteritis: New Insights, New Therapies
Gary S. Hoffman, Professor of Medicine, Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, Cleveland Clinic/Lerner College of Medicine, Cleveland, OH, USA
How to develop behavioural interventions to reduce cardiovascular risk in patients with rheumatoid arthritis
Holly John, Rheumatology Research Fellow, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK
Polyarticular JIA
Sylvia S.M. Kamphuis, MD, PhD, Dr, Pediatric rheumatologist/Immunologist, Sophia Children’s Hospital, Erasmus University MC, Rotterdam, THE NETHERLANDS
Amyloidosis
Jonathan Kay, M.D., Director of Clinical Research/ Professor of Medicine, Divis. of Rheumatology/ University of Massachusetts Medical School, UMass Memorial Medical Center, Worcester, Massachusetts, USA
How to manage a pregnant patient with systemic lupus (SLE)
Rodanthi C. Kitridou, MD, FACP, MACR, Professor Emerita of Medicine (Rheumatology) USC Keck School of Medicine, Los Angeles, USA
Novel approaches to the therapy of osteoarthritis: Joint distraction
Floris Lafeber, Manager of Research, University Medical Centre Utrecht, Rheumatology (F02.127), THE NETHERLANDS
Treatment options in OA and what we have learned from the GAIT Trial
Nancy Lane, Professor of Medicine and Rheumatology, University of California at Davis Medical Center, California, USA
Vasculitis: Disease Evaluation and the Results of the EUVAS Trials
Raashid Luqmani, Professor of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, UK
Current standards of research reporting: reporting guidelines for clinical and laboratory research
Ana Marušić, MD, PhD, Prof, Department of Anatomy and Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia
Clinical Evaluation of Biologics: Can biology help?
Joan T. Merrill, Head, Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma, USA
Patients' expectations of rheumatology services - How can RA guidelines help patients to solve unmet needs?
Susan Oliver, Nurse Consultant Rheumatology, Independent Nurse Consultant, Susan Oliver Associates, Devon, UK
Crystal Arthritis: Gout
Eliseo Pascual, Professor of Medicine, University Migel Hernandez and Head Rheumatology Section, Hospital General Universitario de Alicante, Spain
New Metabolic Biomarkers and Target for Treatment in SLE
Andras Perl, Professor of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, Chief, Division of Rheumatology, Co-Director, M.D., Ph.D. Program, State University of New York, UMU, College of Medicine, USA
New Developments in Treatments of Lupus Syndrome
Michelle Petri, Professor of Medicine, Director of Lupus Center, Johns Hopkins, Baltimore, USA
Back Pain in Children and Adolescents
Update on Diagnosis and Management of JIA
Ross Petty, Professor, University of British Columbia and British Columbia’s Children’s Hospital, CANADA
Pain in a daily reality
Gina Plunkett, Chairperson, Chronic Pain Ireland, IRELAND
Macrophage activation syndrome secondary to Rheumatic Diseases
Athimalaipet Ramanan, Dr, Consultant Paediatric Rheumatologist, Bristol Royal Hospital for Children & Royal National Hospital for Rheumatic Diseases, UK
How to Evaluate and Treat Myositis
Lisa Rider, MD, Deputy Chief, Environmental Autoimmunity Group, National Institute of Environmental Health Science, National Institutes of Health, Bethesda, USA
Biomarkers for Lupus Nephritis
How to diagnose and treat Lupus Nephritis
Brad H. Rovin, Professor of Medicine and Pathology, Vice Chairman of Research for Internal Medicine, Director, Division of Nephrology, The Ohio State University College of Medicine, Columbus, Ohio, USA
How to treat Behçet's disease
Peter Sfikakis, Professor, University of Athens, GREECE
The mosaic of autoimmunity; the role of infections in APS
Yehuda Shoenfeld, Professor, Head, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center (affiliated to Tel-Aviv University), ISRAEL
SSc-Interstitial Lung Disease
Richard Silver, Distinguished University Professor, Interim Chairman, Department of Medicine, Medical University of South Carolina, USA
Vascular disease in systemic sclerosis evolving concepts
Maria Trojanowska, PhD, Professor of Medicine, Director, Arthritis Center, Boston University School of Medicine, Boston, USA
New developments in the management of RA
Mart A.F.J. van de Laar, Professor, Dr., Rheumatologist, Medisch Spectrum Twente & University Twente, THE NETHERLANDS
Accelerating Scleroderma Research Toward a Cure
John Varga, John and Nancy Hughes Distinguished Professor in Rheumatology, NorthWestern University in Chicago, Feinberg School of Medicine, USA
Pathophysiology of Psoriatric Arthritis
Douglas Veale, Professor of Rheumatology, St’ Vincent’s University Hospital, Dublin, IRELAND
Pharmaceutical Research and the Emerging Economies
Jack T. Watters, Vice President for External Medical Affairs, Pfizer, NY, USA
Systemic Juvenile Idiopathic arthritis
Patricia Woo, Emeritus Professor, Paediatric Rheumatology, University College London, UK
Biologics in children with JIA: Indications and Long Term Risks
Nico Wulfraat, Dept. Pediatric Immunology, University Medical Center Utrecht, THE NETHERLANDS
How to diagnose Behçet's disease
Hasan Yazici, Professor and Chief Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, TURKEY
